Heightened Vigilance Needed When Patients Are Prescribed GLP-1 and GIP Agonists
Diabetes Mellitus, Type 2
Glucagon-Like Peptide 1
Humans
Hypoglycemic Agents
Gastric Inhibitory Polypeptide
DOI:
10.1001/jamainternmed.2024.3732
Publication Date:
2024-08-05T15:06:33Z
AUTHORS (3)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (10)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....